Breaking News Instant updates and real-time market news.

GPRO

GoPro

$7.52

-0.05 (-0.66%)

, SNAP

Snap

$13.69

-0.815 (-5.62%)

10:39
01/08/18
01/08
10:39
01/08/18
10:39

On The Fly: Top five analyst downgrades

Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. GoPro (GPRO) downgraded to Neutral from Buy at Longbow with analyst Joe Wittine saying his channel checks confirmed the holidays missed the company's plan and late quarter $100 price cuts were not enough to save the quarter. 2. Snap (SNAP) downgraded to Hold from Buy at Jefferies with analyst Brent Thill saying he continues to have optimism around Snap's platform, but believes "fundamental execution needs to be shown" before he can be more positive on the name. 3. Cirrus Logic (CRUS) downgraded to Sector Weight from Overweight at KeyBanc with analyst John Vinh citing his "disappointment" with the current iPhone cycle and the lack of meaningful content gains until 2019. 4. Pandora (P) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst Benjamin Swinburne noting that the company's core free product has not evolved meaningfully and faces continued innovation by Spotify, Apple (AAPL) and Amazon (AMZN) while also being pressured by free music available on Google's (GOOG) YouTube. 5. GrubHub (GRUB) downgraded to Neutral from Outperform at Wedbush with analyst Aaron Turner saying that while he continues to like the company's market opportunity and competitive positioning, the current peak valuation of shares accurately reflects these positive dynamics. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

GPRO

GoPro

$7.52

-0.05 (-0.66%)

SNAP

Snap

$13.69

-0.815 (-5.62%)

CRUS

Cirrus Logic

$53.89

0.03 (0.06%)

P

Pandora

$4.80

-0.375 (-7.25%)

GRUB

GrubHub

$71.38

-1.595 (-2.19%)

  • 08

    Jan

  • 08

    Jan

  • 09

    Jan

  • 09

    Jan

  • 11

    Jan

  • 23

    Jan

  • 07

    Feb

  • 26

    Feb

GPRO GoPro
$7.52

-0.05 (-0.66%)

01/08/18
01/08/18
DOWNGRADE

Neutral
GoPro downgraded ahead of expected negative preannouncement at Longbow
As previously reported, Longbow analyst Joe Wittine downgraded GoPro to Neutral from Buy, predicting the company will issue a negative preannouncement this week in concert with its appearance at the CES event. His channel checks confirmed the holidays missed the company's plan and late quarter $100 price cuts were not enough to save the quarter, Wittine tells investors. He hoped for a stronger-than-typical Q1 sell-in, but that has also become less likely based on channel inventory, added Wittine.
01/08/18
LBOW
01/08/18
DOWNGRADE
LBOW
Neutral
GoPro downgraded to Neutral from Buy at Longbow
01/08/18
JPMS
01/08/18
NO CHANGE
Target $9
JPMS
Overweight
GoPro price target lowered to $9 from $13 at JPMorgan
JPMorgan analyst Paul Coster lowered his price target for GoPro shares to $9 citing today's negative preannouncement. The analyst now assumes lower pricing and gross margins through 2019. Offsetting this somewhat is reduced operating expenses from GoPro's restructuring initiatives, Coster tells investors in a research note. He keeps an Overweight rating on the shares. The analyst still believes a return to profitability is probable in 2018. GoPro in morning trading is off the day's lows, but the stock remains down 21% to $5.98.
11/27/17
MSCO
11/27/17
NO CHANGE
MSCO
Morgan Stanley checks 'concerning' for GoPro demand
Morgan Stanley analyst Yuuji Anderson said the firm's checks pointed to improved sell-through and receptivity for GoPro's (GPRO) HERO6 camera, but that demand for the older HERO5 appears to be behind targets. He called the early holiday season checks "concerning," saying the combined demand for those two cameras is not sufficiently offsetting the lack of an entry-level product. Increased demand for the Ionic smartwatch and demand for older products that appears in-line with expectations leads Anderson to think Fitbit (FIT) is tracking to an in-line Q4, he said. Meanwhile, sell-through and receptivity for Garmin's (GRMN) Vivoactive 3 has been very good, Anderson added.
SNAP Snap
$13.69

-0.815 (-5.62%)

01/08/18
JEFF
01/08/18
DOWNGRADE
Target $15
JEFF
Hold
Snap downgraded to Hold from Buy at Jefferies
Jefferies analyst Brent Thill downgraded Snap to Hold with an unchanged price target of $15. The camera company closed Friday down 9c to $14.50. The analyst continues to have optimism around Snap's platform, but believes "fundamental execution needs to be shown" before he can be more positive on the name. Some negatives behind the app redesign could "lead to some turbulence in usage and adoption when rolled out," Thill tells investors in a research note. The analyst views the shares, currently trading at 18 times his 2018 revenue estimate, as fully valued.
01/08/18
SBSH
01/08/18
NO CHANGE
SBSH
Citi Q4 checks positive for Facebook and Twitter, mixed for Snap
Citi analyst Mark May says his early Q4 channel checks with two social marketing platforms, 4C Insights and Kenshoo, are positive for both Facebook (FB) and Twitter (TWTR) and mixed for Snap (SNAP). Jefferies this morning downgraded Snap to Hold from Buy. Citi's checks suggest that growth in spend across the Facebook platform remains strong and that the company's Q4 revenue could exceed consensus forecasts, May tells investors in a research note. 4C's data also suggests potential upside to Twitter (TWTR) revenue forecasts, and "potential disappointing revenue results" from Snap, May adds. While 4C just started supporting Snapchat in the second half of 2016, making its year-over-year unreliable, its data show client spend on the platform increased 22% sequentially Q4 as compared with 38% sequential growth in Q3, the analyst adds. He believes this suggests a potential Q4 revenue miss from Snap.
01/05/18
SBSH
01/05/18
NO CHANGE
Target $1400
SBSH
Buy
Citi names Amazon top Internet pick for 2018, ups target to $1,400
Citi analyst Mark May remains bullish on the consumer Internet sector, especially over the near term. The analyst believes a "positive, tax reform fueled, business climate" should benefit the end-markets of the companies in the space. After outperformance in 2017, however, he recommends being more selective in 2018. Amazon.com (AMZN) moves up a spot to become his top-ranked pick for 2018. May sees the combination of greater than 30% sales growth, margin expansion and the current valuation as a "compelling mix." He raised his price target for Amazon shares to $1,400 from $1,250. May's most- to least-favored stocks under coverage, in order, are: Amazon, Expedia (EXPE), Facebook (FB), Priceline (PCLN), Alphabet (GOOGL), eBay (EBAY), Yelp (YELP), Twitter (TWTR), TripAdvisor (TRIP), Netflix (NFLX), GrubHub (GRUB), GoDaddy (GDDY), Despegar.com (DESP), trivago (TRVG), LendingClub (LC), Wayfair (W), Snap (SNAP), Zillow (ZG), Blue Apron (APRN) and Roku (ROKU), which he downgraded this morning to Sell.
01/04/18
01/04/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Roku (ROKU) downgraded to Underweight from Equal Weight at Morgan Stanley with analyst Benjamin Swinburne telling investors that he believes the market has overreacted following the company's stronger than expected third quarter results. 2. Snap (SNAP) downgraded to Underperform from Market Perform at Cowen with analyst John Blackledge saying Blackledge's Ad Buyer Survey results for Snap were mixed with modest share gains of Social/Video budgets in 2018/19 despite ranking ROI, data, and targeting ranking the lowest. 3. Western Digital (WDC) downgraded to Market Perform from Outperform at BMO Capital with analyst Tim Long saying the near-term fundamentals for the company remain healthy, but limited upside for growth in margins and revenue due to a more balanced supply-demand will keep the stock in a trading range. 4. Tableau (DATA) downgraded to Sector Weight from Overweight at KeyBanc with analyst Brent Bracelin saying the risk/reward is more balanced following the 64% rise in shares in 2017. 5. MasterCard (MA) downgraded to Outperform from Top Pick at RBC Capital with analyst Daniel Perlin saying the stock was a "monster" in 2017 with a 47% rise, and his investment thesis of accelerating top-line growth, tailwinds from higher oil prices and favorable FX, and global conversion to electronic payments remains in place. The analyst attributes the downgrade to "repositioning group headings" going into FY18. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
CRUS Cirrus Logic
$53.89

0.03 (0.06%)

01/08/18
KEYB
01/08/18
DOWNGRADE
KEYB
Sector Weight
Cirrus Logic downgraded to Sector Weight from Overweight at KeyBanc
KeyBanc analyst John Vinh downgraded Cirrus Logic (CRUS) to Sector Weight citing his "disappointment" with the current iPhone cycle and the lack of meaningful content gains until 2019. While iPhone X supply has improved meaningfully and remains very lean, feedback indicates sell-through has been somewhat disappointing, Vinh tells investors in a research note following his monthly surveys. The analyst recommends investors continue to own Apple (AAPL), Broadcom (AVGO) and Skyworks (SWKS).
11/06/17
KEYB
11/06/17
NO CHANGE
KEYB
Carrier surveys indicate strong demand, tight supply for iPhone X, says KeyBanc
KeyBanc analyst John Vinh says surveys at U.S. carriers on the iPhone X launch day and throughout the weekend indicate healthy initial response to Apple's (AAPL) new flagship model. Further, his surveys indicate most of the stores were sold out within a few hours after opening despite limited promotional activity. Supply was scarce as most T-Mobile (TMUS) and Sprint (S) stores indicated that they had not received any iPhone X shipments, and several AT&T (T) and Verizon (VZ) stores estimated they will need to wait until December before receiving additional shipments, he contends. Vihn's favorite Apple-related suppliers are Broadcom (AVGO), Cirrus Logic (CRUS), Cypress Semiconductor (CY), and Skyworks (SWKS).
10/16/17
KEYB
10/16/17
NO CHANGE
KEYB
Apple supply chain to remain range-bound, says KeyBanc
KeyBanc analyst John Vinh says that because of supply constraints associated with the iPhone X, he anticipates Apple (AAPL) supply chain stocks will likely remain range-bound in the near term, given constraints make upside to estimates less likely, and constraints make it hard to assess true demand for the iPhone X. Additionally, his latest carrier survey indicates relatively lean iPhone 8 inventories despite muted demand and slightly higher demand for the iPhone 7. The analyst recommends investors continue to own Broadcom (AVGO), Cirrus Logic (CRUS), and Skyworks (SWKS).
09/21/17
CHLM
09/21/17
NO CHANGE
CHLM
Customers waiting for Apple iPhone X with facial recognition, says Craig-Hallum
Craig-Hallum analyst Tony Stoss notes Apple (AAPL) suppliers sold off yesterday as order shipment dates for the iPhone 8/8 Plus remain relatively short for a new iPhone launch. The analyst thinks customers are waiting for the iPhone X with facial recognition. Stoss reiterates a Buy rating for Skyworks (SWKS), Broadcom (AVGO), Qorvo (QRVO), STMicroelectronics (STM), Cypress Semiconductor (CY), Knowles (KN) a Buy, and a Hold for Cirrus Logic (CRUS) and Synaptics (SYNA).
P Pandora
$4.80

-0.375 (-7.25%)

01/08/18
MSCO
01/08/18
DOWNGRADE
Target $6
MSCO
Equal Weight
Pandora downgraded to Equal Weight from Overweight at Morgan Stanley
Morgan Stanley analyst Benjamin Swinburne downgraded Pandora (P) to Equal Weight from Overweight, noting that the company's core free product has not evolved meaningfully and faces continued innovation by Spotify, Apple (AAPL) and Amazon (AMZN) while also being pressured by free music available on Google's (GOOG) YouTube. While engagement is challenged, is increasingly clear that consumers' willingness to accept more ads is limited, which also puts pressure on monetization and means growing ad revenue in 2018 is "no longer a given," he tells investors. Swinburne lowered his price target on Pandora shares to $6 from $12.
01/02/18
RHCO
01/02/18
NO CHANGE
Target $7
RHCO
Hold
Pandora 2018 EBITDA consensus is too high, says SunTrust
SunTrust analyst Matthew Thornton lowered his price target on Pandora (P) to $7 from $8 and kept his Hold rating, saying that while he is positive on the company's initiatives to boost User Hours and Subscriptions, they will take time and investment to materialize. Thornton says the consensus EBITDA view of -$42M is too high, given the expected rise in costs. The analyst also points to "intense" competition in streaming music as well as potential entry in the space at Facebook (FB), based on its music hires and content licensing.
12/12/17
PIPR
12/12/17
NO CHANGE
Target $9
PIPR
Overweight
Piper likes Pandora risk/return at current share levels
After traveling with management, Piper Jaffray analyst Stan Meyers says he likes risk/return profile of Pandora Media shares at current levels. The analyst left the meetings "more comfortable with the evolving Pandora story." He sees improving monetization, listenership growth and cost reductions driving Pandora's growth. The analyst reiterates an Overweight rating on the shares with a $9 price target.
12/05/17
EVER
12/05/17
INITIATION
Target $5.5
EVER
In Line
Pandora initiated with an In Line at Evercore ISI
Evercore ISI analyst initiated Pandora with an In Line and $5.50 price target.
GRUB GrubHub
$71.38

-1.595 (-2.19%)

01/05/18
OPCO
01/05/18
NO CHANGE
Target $80
OPCO
Outperform
GrubHub price target raised to $80 from $66 at Oppenheimer
Oppenheimer analyst Jason Helfstein raised his price target for GrubHub to $80 saying the company's setup is favorable heading into 2018. Multiple catalysts remain for GrubHub, including incremental acquisitions, greater than expected EBITDA/order contribution from previously acquired assets, Eat24 integration timing upside and favorable weather comparables in the first half of 2018, Helfstein tells investors in a research note. The analyst keeps an Outperform rating on the shares.
01/08/18
01/08/18
DOWNGRADE
Target $70

Neutral
GrubHub downgraded to Neutral at Wedbush
As previously reported, Wedbush analyst Aaron Turner downgraded GrubHub to Neutral from Outperform saying that while he continues to like the company's market opportunity and competitive positioning, the current peak valuation of shares accurately reflects these positive dynamics. The analyst also raised his price target on the shares to $70 from $65.
01/08/18
WELS
01/08/18
NO CHANGE
Target $68
WELS
Market Perform
GrubHub price target raised to $68 from $58 at Wells Fargo
Wells Fargo analyst Peter Stabler raised his price target for GrubHub to $68 from $58 as he believes 2018 will benefit from many of the same underlying trends as in 2017, including the widening use of artificial intelligence, the increasing reliance on mobile, and the growing importance of Cloud. The analyst reiterates a Market Perform rating on the shares.
01/08/18
WEDB
01/08/18
DOWNGRADE
WEDB
Neutral
GrubHub downgraded to Neutral from Outperform at Wedbush

TODAY'S FREE FLY STORIES

BMY

Bristol-Myers

$62.28

0.45 (0.73%)

15:26
01/20/18
01/20
15:26
01/20/18
15:26
Hot Stocks
Opdivo, Yervoy combo demonstrates activity in patients with dMMR, MSI-H mCRC »

Bristol-Myers Squibb…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

  • 05

    Feb

  • 08

    Feb

  • 05

    Mar

  • 08

    Mar

EXEL

Exelixis

$28.00

0.14 (0.50%)

, RHHBY

Roche

$30.69

0.18 (0.59%)

15:22
01/20/18
01/20
15:22
01/20/18
15:22
Hot Stocks
Exelixis presents updated results from Phase 1b clinical trial in CRC »

Exelixis (EXEL) announced…

EXEL

Exelixis

$28.00

0.14 (0.50%)

RHHBY

Roche

$30.69

0.18 (0.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

  • 01

    Feb

  • 08

    Feb

  • 15

    Feb

  • 23

    Feb

ARRY

Array BioPharma

$13.14

0.26 (2.02%)

15:17
01/20/18
01/20
15:17
01/20/18
15:17
Hot Stocks
Array BioPharma updates results from BEACON Phase 3 trial »

Array BioPharma and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jun

  • 30

    Jun

SO

Southern Company

$44.44

-0.46 (-1.02%)

15:13
01/20/18
01/20
15:13
01/20/18
15:13
Hot Stocks
Southern Company accelerates restoration efforts in Puerto Rico »

Southern Company…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TECK

Teck Resources

$29.43

0.19 (0.65%)

15:10
01/20/18
01/20
15:10
01/20/18
15:10
Hot Stocks
Teck Resources announces Elkview incident »

Teck Resources announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Feb

TWTR

Twitter

$23.66

-0.38 (-1.58%)

14:03
01/20/18
01/20
14:03
01/20/18
14:03
Hot Stocks
Twitter begins notifying users exposed to Russian propaganda during elections »

Twitter, which is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 07

    Feb

  • 08

    Feb

  • 28

    Feb

SPY

SPDR S&P 500 ETF Trust

$280.41

1.27 (0.45%)

, SPX

S&P 500

13:58
01/20/18
01/20
13:58
01/20/18
13:58
Periodicals
Government shuts down on anniversary of Trump presidency, Reuters reports »

President's Trump…

SPY

SPDR S&P 500 ETF Trust

$280.41

1.27 (0.45%)

SPX

S&P 500

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$181.29

1.49 (0.83%)

, NYT

New York Times

$21.90

1.7 (8.42%)

13:48
01/20/18
01/20
13:48
01/20/18
13:48
Periodicals
NY Times stock jumps after Facebook's announcement, Recode reports »

Facebook (FB) CEO Mark…

FB

Facebook

$181.29

1.49 (0.83%)

NYT

New York Times

$21.90

1.7 (8.42%)

NWSA

News Corp.

$17.22

0.21 (1.23%)

FOXA

21st Century Fox

$36.65

0.47 (1.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 31

    Jan

  • 07

    Feb

  • 07

    Feb

  • 28

    Feb

WMT

Walmart

$104.59

0.29 (0.28%)

13:36
01/20/18
01/20
13:36
01/20/18
13:36
Periodicals
Still time to shop Walmart shares as company makes changes, Barron's says »

In a follow-up story,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

AAPL

Apple

$178.46

-0.8 (-0.45%)

, NFLX

Netflix

$220.46

0.13 (0.06%)

08:59
01/20/18
01/20
08:59
01/20/18
08:59
Periodicals
Netflix among likely candidates for an Apple purchase, Barron's says »

Especially for tech…

AAPL

Apple

$178.46

-0.8 (-0.45%)

NFLX

Netflix

$220.46

0.13 (0.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 30

    Jan

  • 01

    Feb

BA

Boeing

$337.73

-2.43 (-0.71%)

08:50
01/20/18
01/20
08:50
01/20/18
08:50
Periodicals
Boeing not a sell just yet, Barron's says »

Boeing stock has come…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jan

  • 21

    Feb

AAPL

Apple

$178.46

-0.8 (-0.45%)

, EADSY

Airbus

$28.43

0.755 (2.73%)

08:24
01/20/18
01/20
08:24
01/20/18
08:24
Hot Stocks
Week in review: How Trump's policies moved stocks »

Catch up on the top…

AAPL

Apple

$178.46

-0.8 (-0.45%)

EADSY

Airbus

$28.43

0.755 (2.73%)

BA

Boeing

$337.73

-2.43 (-0.71%)

VZ

Verizon

$51.91

0.36 (0.70%)

NYT

New York Times

$21.90

1.7 (8.42%)

TWX

Time Warner

$93.36

0.39 (0.42%)

DIS

Disney

$110.59

0.17 (0.15%)

TIME

Time Inc.

$18.55

0.05 (0.27%)

AMZN

Amazon.com

$1,294.58

1.26 (0.10%)

BAC

Bank of America

$31.72

0.24 (0.76%)

GS

Goldman Sachs

$256.12

5.15 (2.05%)

BK

BNY Mellon

$56.61

1.26 (2.28%)

WLKP

Westlake Chemical Partners

$24.45

-0.1 (-0.41%)

MON

Monsanto

$120.66

1.8 (1.51%)

DLTR

Dollar Tree

$114.73

1.83 (1.62%)

CE

Celanese

$112.96

1.93 (1.74%)

LYB

LyondellBasell

$119.92

3.03 (2.59%)

TSE

Trinseo

$79.45

2.2 (2.85%)

EYE

National Vision

$43.13

1.12 (2.67%)

ETFC

E-Trade

$54.28

0.63 (1.17%)

LPLA

LPL Financial

$59.03

0.53 (0.91%)

AMTD

TD Ameritrade

$55.17

0.21 (0.38%)

SCHW

Charles Schwab

$55.48

0.15 (0.27%)

ADS

Alliance Data

$261.82

5.88 (2.30%)

FISV

Fiserv

$138.11

0.17 (0.12%)

FLT

FleetCor

$206.65

3.4 (1.67%)

HAWK

Blackhawk

$45.25

0.1 (0.22%)

MTZ

MasTec

$53.30

1.25 (2.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 23

    Jan

  • 25

    Jan

  • 25

    Jan

  • 26

    Jan

  • 31

    Jan

  • 31

    Jan

  • 31

    Jan

  • 01

    Feb

  • 01

    Feb

  • 01

    Feb

  • 02

    Feb

  • 06

    Feb

  • 07

    Feb

  • 15

    Feb

  • 16

    Feb

  • 21

    Feb

  • 08

    Mar

  • 18

    Mar

CME

CME Group

$154.28

2.07 (1.36%)

, GS

Goldman Sachs

$256.12

5.15 (2.05%)

04:55
01/20/18
01/20
04:55
01/20/18
04:55
Conference/Events
American Bar Association to hold annual meeting »

Derivatives & Futures…

CME

CME Group

$154.28

2.07 (1.36%)

GS

Goldman Sachs

$256.12

5.15 (2.05%)

BP

BP

$42.40

-0.5 (-1.17%)

C

Citi

$78.30

0.91 (1.18%)

BAC

Bank of America

$31.72

0.24 (0.76%)

CS

Credit Suisse

$19.06

0.13 (0.69%)

CRL

Charles River

$107.89

1.22 (1.14%)

MS

Morgan Stanley

$57.46

1.62 (2.90%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jan

  • 24

    Jan

  • 31

    Jan

  • 01

    Feb

  • 15

    Feb

AMGN

Amgen

$189.28

1.69 (0.90%)

, BAYRY

Bayer

$32.05

0.235 (0.74%)

04:55
01/20/18
01/20
04:55
01/20/18
04:55
Conference/Events
American Society of Clinical Oncology to hold a symposium »

2018 ASCO…

AMGN

Amgen

$189.28

1.69 (0.90%)

BAYRY

Bayer

$32.05

0.235 (0.74%)

BLRX

BioLineRx

$1.09

-0.02 (-1.80%)

BMY

Bristol-Myers

$62.28

0.45 (0.73%)

CELG

Celgene

$102.65

0.93 (0.91%)

DNA

Bought by RHHBY

ESALY

Eisai

$56.88

0.115 (0.20%)

EXEL

Exelixis

$28.00

0.14 (0.50%)

HALO

Halozyme

$17.98

0.13 (0.73%)

INCY

Incyte

$93.16

1.24 (1.35%)

IPSEY

Ipsen

$34.65

0.75 (2.21%)

LXRX

Lexicon

$10.44

0.2 (1.95%)

MGNX

MacroGenics

$19.19

0.3 (1.59%)

MRK

Merck

$61.28

0.15 (0.25%)

NVS

Novartis

$86.94

0.53 (0.61%)

SNY

Sanofi

$44.60

0.09 (0.20%)

ONCY

Oncolytics

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 25

    Jan

  • 25

    Jan

  • 02

    Feb

  • 03

    Feb

  • 05

    Feb

  • 08

    Feb

  • 15

    Feb

  • 16

    Feb

  • 02

    Mar

  • 05

    Mar

  • 08

    Mar

  • 25

    Mar

  • 03

    Apr

  • 23

    Apr

  • 30

    Apr

  • 02

    May

  • 17

    May

  • 28

    May

  • 23

    Oct

WLFC

Willis Lease

$26.66

0.05 (0.19%)

18:59
01/19/18
01/19
18:59
01/19/18
18:59
Hot Stocks
Willis Lease announces $1,000 bonus for employees »

Willis Lease announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DPS

Dr Pepper Snapple

$96.35

1.03 (1.08%)

18:13
01/19/18
01/19
18:13
01/19/18
18:13
Hot Stocks
Dr Pepper to become official sponsor of esports team TSM »

Dr Pepper announced it is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RCII

Rent-A-Center

$11.70

0.09 (0.78%)

17:53
01/19/18
01/19
17:53
01/19/18
17:53
Hot Stocks
Vintage Capital in standstill pact with Rent-A-Center »

On January 17, Vintage…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AR

Antero Resources

$18.74

-0.59 (-3.05%)

17:44
01/19/18
01/19
17:44
01/19/18
17:44
Recommendations
Antero Resources analyst commentary at MUFG »

Antero Resources price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

T

AT&T

$37.21

0.06 (0.16%)

, TWX

Time Warner

$93.36

0.39 (0.42%)

17:44
01/19/18
01/19
17:44
01/19/18
17:44
Periodicals
AT&T requesting docs from companies in Time Warner deal hearing, Reuters says »

AT&T (T) is…

T

AT&T

$37.21

0.06 (0.16%)

TWX

Time Warner

$93.36

0.39 (0.42%)

VZ

Verizon

$51.91

0.36 (0.70%)

CMCSA

Comcast

$42.50

0.65 (1.55%)

CMCSK

Comcast

DISH

Dish

$45.26

0.1 (0.22%)

CHTR

Charter

$366.05

0.8 (0.22%)

DIS

Disney

$110.59

0.17 (0.15%)

VIA

Viacom

$39.20

-0.5 (-1.26%)

VIAB

Viacom

$33.36

-0.59 (-1.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 24

    Jan

  • 24

    Jan

  • 31

    Jan

  • 02

    Feb

  • 06

    Feb

  • 08

    Feb

  • 08

    Feb

GRPN

Groupon

$5.57

0.46 (9.00%)

17:44
01/19/18
01/19
17:44
01/19/18
17:44
Hot Stocks
Groupon announces Chief Product Officer Jay Sullivan resigns »

On January 17, Jay…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CELG

Celgene

$102.65

0.93 (0.91%)

17:41
01/19/18
01/19
17:41
01/19/18
17:41
Hot Stocks
Celgene's Abraxane exceeds primary endpoint target in pancreatic cancer trial »

Celgene announced primary…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

  • 25

    Jan

  • 16

    Feb

  • 25

    Mar

VALU

Value Line

$19.60

0.3 (1.55%)

17:40
01/19/18
01/19
17:40
01/19/18
17:40
Hot Stocks
Value Line reaffirms $3M stock repurchase program »

The Board of Directors…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VALU

Value Line

$19.60

0.3 (1.55%)

17:39
01/19/18
01/19
17:39
01/19/18
17:39
Hot Stocks
Value Line declares special dividend of 20c per share »

Payable on March 9 to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZEAL

Zealand Pharma

$15.05

-0.78 (-4.93%)

17:34
01/19/18
01/19
17:34
01/19/18
17:34
Hot Stocks
Zealand Pharma: FDA approves IND for Phase 3 trials of dasiglucagon in CHI »

The U.S. FDA has approved…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GNMSF

Genmab

$190.75

2.75 (1.46%)

, JNJ

Johnson & Johnson

$147.36

0.44 (0.30%)

17:29
01/19/18
01/19
17:29
01/19/18
17:29
Hot Stocks
Genmab says FDA grants priority review for daratumumab »

Genmab (GNMSF) announced…

GNMSF

Genmab

$190.75

2.75 (1.46%)

JNJ

Johnson & Johnson

$147.36

0.44 (0.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

  • 23

    Jan

  • 16

    Feb

  • 08

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.